Beam Therapeutics (BEAM) Other Gross PP&E Adjustments (2019 - 2025)
Historic Other Gross PP&E Adjustments for Beam Therapeutics (BEAM) over the last 7 years, with Q3 2025 value amounting to $96.2 million.
- Beam Therapeutics' Other Gross PP&E Adjustments rose 3379.87% to $96.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $96.2 million, marking a year-over-year increase of 3379.87%. This contributed to the annual value of $75.3 million for FY2024, which is 2795.44% up from last year.
- Per Beam Therapeutics' latest filing, its Other Gross PP&E Adjustments stood at $96.2 million for Q3 2025, which was up 3379.87% from $88.9 million recorded in Q2 2025.
- In the past 5 years, Beam Therapeutics' Other Gross PP&E Adjustments ranged from a high of $111.5 million in Q2 2022 and a low of -$47.8 million during Q1 2021
- For the 5-year period, Beam Therapeutics' Other Gross PP&E Adjustments averaged around $41.3 million, with its median value being $53.1 million (2023).
- In the last 5 years, Beam Therapeutics' Other Gross PP&E Adjustments tumbled by 50820.05% in 2021 and then soared by 63548.6% in 2023.
- Over the past 5 years, Beam Therapeutics' Other Gross PP&E Adjustments (Quarter) stood at -$5.7 million in 2021, then soared by 459.54% to $20.5 million in 2022, then skyrocketed by 186.6% to $58.8 million in 2023, then rose by 27.95% to $75.3 million in 2024, then rose by 27.82% to $96.2 million in 2025.
- Its Other Gross PP&E Adjustments was $96.2 million in Q3 2025, compared to $88.9 million in Q2 2025 and $80.5 million in Q1 2025.